English

BODISEN BIOTECH, INC

EDGAR

Quarterly report (10-Q) · filed 2013-09-11

55 filing records in this dataset, filed from 2003-03-28 to 2013-09-11. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.78 million USD

2011-09-30 · USD

Exact inputs and evidence

Revenue: 1781006 USD Source

Operating margin

-45.68%

2011-09-30 · %

Exact inputs and evidence

Operating Income: -813641 USD Source
Revenue: 1781006 USD Source

Operating cash flow

-493 thousand USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -2830406 USD Source
Operating Cash Flow: -2337832 USD Source

Free cash flow

-493 thousand USD

2011-09-30 · USD

Exact inputs and evidence

Operating Cash Flow: -2830406 USD Source
Operating Cash Flow: -2337832 USD Source
Capital Expenditure: 538 USD Source
Capital Expenditure: 528 USD Source

Cash and cash equivalents: 948 thousand USD 2011-09-30 Source
Exact value

948137 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2013-09-11.

Financial data available through: 2009-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 6 of 11 periods available· newest 2009-12-31
Operating income: 6 of 11 periods available· newest 2009-12-31
Net income: 6 of 11 periods available· newest 2009-12-31
Operating cash flow: 6 of 11 periods available· newest 2009-12-31
Capital expenditure: 6 of 11 periods available· newest 2009-12-31
Total assets: 6 of 11 periods available· newest 2009-12-31
Total liabilities: 1 of 11 periods available· newest 2009-12-31
Current assets: 5 of 11 periods available· newest 2009-12-31
Current liabilities: 6 of 11 periods available· newest 2009-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2009-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-42.7%

Prior period

USD 7.59 million

2008-01-01 – 2008-12-31
Current period

USD 4.35 million

2009-01-01 – 2009-12-31

Exact inputs and evidence

4351164 − 7594458 = -3243294 USD

7594458 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
4351164 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · BODISEN BIOTECH, INC · 2009-12-31 BODISEN BIOTECH, INC (edgar:1178552) Year-over-year change in Revenue: -3243294 USD Concept: fundies:Revenue Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4351164 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#4742 Input fundies:Revenue: 7594458 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#4742
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 7.43 million

Prior period

−USD 6.92 million

2008-01-01 – 2008-12-31
Current period

USD 510,289

2009-01-01 – 2009-12-31

Exact inputs and evidence

510289 − -6919037 = 7429326 USD

-6919037 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
510289 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · BODISEN BIOTECH, INC · 2009-12-31 BODISEN BIOTECH, INC (edgar:1178552) Year-over-year change in Net income: 7429326 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 510289 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6478 Input fundies:NetIncome: -6919037 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6478
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-98.7%

Prior period

USD 6.16 million

2008-01-01 – 2008-12-31
Current period

USD 79,511

2009-01-01 – 2009-12-31

Exact inputs and evidence

79511 − 6161699 = -6082188 USD

6161699 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
79511 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · BODISEN BIOTECH, INC · 2009-12-31 BODISEN BIOTECH, INC (edgar:1178552) Year-over-year change in Operating cash flow: -6082188 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 79511 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6785 Input fundies:OperatingCashFlow: 6161699 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6785
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%

Prior period

USD 64,871

2008-01-01 – 2008-12-31
Current period

USD 0

2009-01-01 – 2009-12-31

Exact inputs and evidence

0 − 64871 = -64871 USD

64871 USD · 2008-01-01 – 2008-12-31
Inspect prior input Prior source
0 USD · 2009-01-01 – 2009-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · BODISEN BIOTECH, INC · 2009-12-31 BODISEN BIOTECH, INC (edgar:1178552) Year-over-year change in Capital expenditure: -64871 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6825 Input fundies:CapitalExpenditure: 64871 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6825
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2009 2009-01-01 – 2009-12-31

Revenue USD 4.35 million 100% of revenue
Cost of revenue USD 3.86 million 89% of revenue
Operating expenses USD 1.31 million 30% of revenue
Operating income −USD 817,411 −19% of revenue
Tax, interest and other Derived −USD 1.33 million −31% of revenue
Net income USD 510,289 12% of revenue

Cash

Operating cash flow USD 79,511 1.8% of revenue
Capital expenditure USD 0 0% of revenue
Free cash flow Derived USD 79,511 1.8% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2004 31%69%
2005 24%71%
2006 Net income was higher than operating income, so the split is not drawn.
2007 Operating loss: operating costs were 311% of revenue.
2008 Operating loss: operating costs were 194% of revenue.
2009 Operating loss: operating costs were 119% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2004 2004-01-01 – 2004-12-31	16225896	11177315 Derived	5048581	21178 Derived	5027403	1532405 Derived	Source 2004-01-01 – 2004-12-31: 16225896 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: 5048581 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: 5027403 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 1968219 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 435814 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	30975350	21902874 Derived	9072476	1651364 Derived	7421112	-1819515 Derived	Source 2005-01-01 – 2005-12-31: 30975350 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 9072476 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 7421112 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 1823015 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 3642530 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	43626984	30068613 Derived	13558371	-172456 Derived	13730827	-6371455 Derived	Source 2006-01-01 – 2006-12-31: 43626984 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 13558371 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 13730827 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: -5920097 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 451358 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	12108579	37672074 Derived	-25563495	-236103 Derived	-25327392	-8027332 Derived	Source 2007-01-01 – 2007-12-31: 12108579 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: -25563495 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -25327392 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: -7932725 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 94607 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	7594458	14721537 Derived	-7127079	-208042 Derived	-6919037	6096828 Derived	Source 2008-01-01 – 2008-12-31: 7594458 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: -7127079 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: -6919037 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 6161699 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 64871 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	4351164	5168575 Derived	-817411	-1327700 Derived	510289	79511 Derived	Source 2009-01-01 – 2009-12-31: 4351164 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: -817411 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 510289 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 79511 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4.4M 2009

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Revenue	16225896	Revenue: 16225896 Open source
20052005-12-31	Revenue	30975350	Revenue: 30975350 Open source
20062006-12-31	Revenue	43626984	Revenue: 43626984 Open source
20072007-12-31	Revenue	12108579	Revenue: 12108579 Open source
20082008-12-31	Revenue	7594458	Revenue: 7594458 Open source
20092009-12-31	Revenue	4351164	Revenue: 4351164 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-42.7% 2009

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Year over year	No prior comparable period	Revenue: 16225896 Open source
20052005-12-31	Year over year	90.9%	Revenue: 30975350 Open source Revenue: 16225896 Open source
20062006-12-31	Year over year	40.8%	Revenue: 43626984 Open source Revenue: 30975350 Open source
20072007-12-31	Year over year	-72.2%	Revenue: 12108579 Open source Revenue: 43626984 Open source
20082008-12-31	Year over year	-37.3%	Revenue: 7594458 Open source Revenue: 12108579 Open source
20092009-12-31	Year over year	-42.7%	Revenue: 4351164 Open source Revenue: 7594458 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -18.8% 2009

Net margin 11.7% 2009

Free cash flow margin 1.8% 2009

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20042004-12-31	Operating margin	31.1%	Operating Income: 5048581 Open source Revenue: 16225896 Open source
20052005-12-31	Operating margin	29.3%	Operating Income: 9072476 Open source Revenue: 30975350 Open source
20062006-12-31	Operating margin	31.1%	Operating Income: 13558371 Open source Revenue: 43626984 Open source
20072007-12-31	Operating margin	-211.1%	Operating Income: -25563495 Open source Revenue: 12108579 Open source
20082008-12-31	Operating margin	-93.8%	Operating Income: -7127079 Open source Revenue: 7594458 Open source
20092009-12-31	Operating margin	-18.8%	Operating Income: -817411 Open source Revenue: 4351164 Open source
20042004-12-31	Net margin	31%	Net Income: 5027403 Open source Revenue: 16225896 Open source
20052005-12-31	Net margin	24%	Net Income: 7421112 Open source Revenue: 30975350 Open source
20062006-12-31	Net margin	31.5%	Net Income: 13730827 Open source Revenue: 43626984 Open source
20072007-12-31	Net margin	-209.2%	Net Income: -25327392 Open source Revenue: 12108579 Open source
20082008-12-31	Net margin	-91.1%	Net Income: -6919037 Open source Revenue: 7594458 Open source
20092009-12-31	Net margin	11.7%	Net Income: 510289 Open source Revenue: 4351164 Open source
20042004-12-31	Free cash flow margin	9.4%	Revenue: 16225896 Open source Operating Cash Flow: 1968219 Open source Capital Expenditure: 435814 Open source
20052005-12-31	Free cash flow margin	-5.9%	Revenue: 30975350 Open source Operating Cash Flow: 1823015 Open source Capital Expenditure: 3642530 Open source
20062006-12-31	Free cash flow margin	-14.6%	Revenue: 43626984 Open source Operating Cash Flow: -5920097 Open source Capital Expenditure: 451358 Open source
20072007-12-31	Free cash flow margin	-66.3%	Revenue: 12108579 Open source Operating Cash Flow: -7932725 Open source Capital Expenditure: 94607 Open source
20082008-12-31	Free cash flow margin	80.3%	Revenue: 7594458 Open source Operating Cash Flow: 6161699 Open source Capital Expenditure: 64871 Open source
20092009-12-31	Free cash flow margin	1.8%	Revenue: 4351164 Open source Operating Cash Flow: 79511 Open source Capital Expenditure: 0 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 79.5K 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Operating cash flow	1968219	Operating Cash Flow: 1968219 Open source
20052005-12-31	Operating cash flow	1823015	Operating Cash Flow: 1823015 Open source
20062006-12-31	Operating cash flow	-5920097	Operating Cash Flow: -5920097 Open source
20072007-12-31	Operating cash flow	-7932725	Operating Cash Flow: -7932725 Open source
20082008-12-31	Operating cash flow	6161699	Operating Cash Flow: 6161699 Open source
20092009-12-31	Operating cash flow	79511	Operating Cash Flow: 79511 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 79.5K 2009

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20042004-12-31	Free cash flow	1532405	Operating Cash Flow: 1968219 Open source Capital Expenditure: 435814 Open source
20052005-12-31	Free cash flow	-1819515	Operating Cash Flow: 1823015 Open source Capital Expenditure: 3642530 Open source
20062006-12-31	Free cash flow	-6371455	Operating Cash Flow: -5920097 Open source Capital Expenditure: 451358 Open source
20072007-12-31	Free cash flow	-8027332	Operating Cash Flow: -7932725 Open source Capital Expenditure: 94607 Open source
20082008-12-31	Free cash flow	6096828	Operating Cash Flow: 6161699 Open source Capital Expenditure: 64871 Open source
20092009-12-31	Free cash flow	79511	Operating Cash Flow: 79511 Open source Capital Expenditure: 0 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

2.6% 2009

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2004-12-31	Liabilities / assets	Not reported	Total Assets: 14799727 Open source
2005-12-31	Liabilities / assets	Not reported	Total Assets: 36291092 Open source
2006-12-31	Liabilities / assets	Not reported	Total Assets: 69196618 Open source
2007-12-31	Liabilities / assets	Not reported	Total Assets: 54994495 Open source
2008-12-31	Liabilities / assets	Not reported	Total Assets: 44358442 Open source
20092009-12-31	Liabilities / assets	2.6%	Total Liabilities: 1150324 Open source Total Assets: 45006093 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

8.43× 2009

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
2004-12-31	Current assets / current liabilities	Not reported	Current Liabilities: 1356946 Open source
20052005-12-31	Current assets / current liabilities	4.23×	Current Assets: 20600285 Open source Current Liabilities: 4873989 Open source
20062006-12-31	Current assets / current liabilities	33.74×	Current Assets: 46240470 Open source Current Liabilities: 1370300 Open source
20072007-12-31	Current assets / current liabilities	13.87×	Current Assets: 19514774 Open source Current Liabilities: 1406704 Open source
20082008-12-31	Current assets / current liabilities	2.23×	Current Assets: 6489144 Open source Current Liabilities: 2905482 Open source
20092009-12-31	Current assets / current liabilities	8.43×	Current Assets: 9696852 Open source Current Liabilities: 1150324 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2004 2004-01-01 – 2004-12-31	USD 5.03 million Exact value Exact value: 5027403 USD 2004-01-01 – 2004-12-31: 5027403 USD Inspect Net Income Open source Share or cite Citation for Net Income · BODISEN BIOTECH, INC · 2004-12-31 BODISEN BIOTECH, INC (edgar:1178552) Net Income: 5027403 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5027403 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-07-021528.txt#9404 The citation records this snapshot. The page link may show a newer release later.	USD 1.97 million Exact value Exact value: 1968219 USD 2004-01-01 – 2004-12-31: 1968219 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BODISEN BIOTECH, INC · 2004-12-31 BODISEN BIOTECH, INC (edgar:1178552) Operating Cash Flow: 1968219 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1968219 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-07-021528.txt#9904 The citation records this snapshot. The page link may show a newer release later.	USD 435,814 Exact value Exact value: 435814 USD 2004-01-01 – 2004-12-31: 435814 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BODISEN BIOTECH, INC · 2004-12-31 BODISEN BIOTECH, INC (edgar:1178552) Capital Expenditure: 435814 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 435814 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-07-021528.txt#10010 The citation records this snapshot. The page link may show a newer release later.	USD 1.53 million Calculation and evidence 1968219 − 435814 USD Exact free cash flow: 1532405 USD 2004-01-01 – 2004-12-31: 1968219 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 435814 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BODISEN BIOTECH, INC · 2004-12-31 BODISEN BIOTECH, INC (edgar:1178552) Free cash flow: 1532405 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1968219 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-07-021528.txt#9904 Input fundies:CapitalExpenditure: 435814 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-07-021528.txt#10010 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	USD 7.42 million Exact value Exact value: 7421112 USD 2005-01-01 – 2005-12-31: 7421112 USD Inspect Net Income Open source Share or cite Citation for Net Income · BODISEN BIOTECH, INC · 2005-12-31 BODISEN BIOTECH, INC (edgar:1178552) Net Income: 7421112 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 7421112 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-07-021528.txt#9404 The citation records this snapshot. The page link may show a newer release later.	USD 1.82 million Exact value Exact value: 1823015 USD 2005-01-01 – 2005-12-31: 1823015 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BODISEN BIOTECH, INC · 2005-12-31 BODISEN BIOTECH, INC (edgar:1178552) Operating Cash Flow: 1823015 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1823015 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-07-021528.txt#9904 The citation records this snapshot. The page link may show a newer release later.	USD 3.64 million Exact value Exact value: 3642530 USD 2005-01-01 – 2005-12-31: 3642530 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BODISEN BIOTECH, INC · 2005-12-31 BODISEN BIOTECH, INC (edgar:1178552) Capital Expenditure: 3642530 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3642530 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-07-021528.txt#10010 The citation records this snapshot. The page link may show a newer release later.	−USD 1.82 million Calculation and evidence 1823015 − 3642530 USD Exact free cash flow: -1819515 USD 2005-01-01 – 2005-12-31: 1823015 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 3642530 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BODISEN BIOTECH, INC · 2005-12-31 BODISEN BIOTECH, INC (edgar:1178552) Free cash flow: -1819515 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1823015 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-07-021528.txt#9904 Input fundies:CapitalExpenditure: 3642530 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-07-021528.txt#10010 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 13.73 million Exact value Exact value: 13730827 USD 2006-01-01 – 2006-12-31: 13730827 USD Inspect Net Income Open source Share or cite Citation for Net Income · BODISEN BIOTECH, INC · 2006-12-31 BODISEN BIOTECH, INC (edgar:1178552) Net Income: 13730827 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 13730827 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-08-022543.txt#6928 The citation records this snapshot. The page link may show a newer release later.	−USD 5.92 million Exact value Exact value: -5920097 USD 2006-01-01 – 2006-12-31: -5920097 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BODISEN BIOTECH, INC · 2006-12-31 BODISEN BIOTECH, INC (edgar:1178552) Operating Cash Flow: -5920097 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -5920097 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-08-022543.txt#7306 The citation records this snapshot. The page link may show a newer release later.	USD 451,358 Exact value Exact value: 451358 USD 2006-01-01 – 2006-12-31: 451358 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BODISEN BIOTECH, INC · 2006-12-31 BODISEN BIOTECH, INC (edgar:1178552) Capital Expenditure: 451358 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 451358 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-08-022543.txt#7363 The citation records this snapshot. The page link may show a newer release later.	−USD 6.37 million Calculation and evidence -5920097 − 451358 USD Exact free cash flow: -6371455 USD 2006-01-01 – 2006-12-31: -5920097 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 451358 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BODISEN BIOTECH, INC · 2006-12-31 BODISEN BIOTECH, INC (edgar:1178552) Free cash flow: -6371455 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -5920097 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-08-022543.txt#7306 Input fundies:CapitalExpenditure: 451358 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-08-022543.txt#7363 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 25.33 million Exact value Exact value: -25327392 USD 2007-01-01 – 2007-12-31: -25327392 USD Inspect Net Income Open source Share or cite Citation for Net Income · BODISEN BIOTECH, INC · 2007-12-31 BODISEN BIOTECH, INC (edgar:1178552) Net Income: -25327392 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -25327392 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-09-016809.txt#6448 The citation records this snapshot. The page link may show a newer release later.	−USD 7.93 million Exact value Exact value: -7932725 USD 2007-01-01 – 2007-12-31: -7932725 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BODISEN BIOTECH, INC · 2007-12-31 BODISEN BIOTECH, INC (edgar:1178552) Operating Cash Flow: -7932725 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7932725 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-09-016809.txt#6724 The citation records this snapshot. The page link may show a newer release later.	USD 94,607 Exact value Exact value: 94607 USD 2007-01-01 – 2007-12-31: 94607 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BODISEN BIOTECH, INC · 2007-12-31 BODISEN BIOTECH, INC (edgar:1178552) Capital Expenditure: 94607 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 94607 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-09-016809.txt#6764 The citation records this snapshot. The page link may show a newer release later.	−USD 8.03 million Calculation and evidence -7932725 − 94607 USD Exact free cash flow: -8027332 USD 2007-01-01 – 2007-12-31: -7932725 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 94607 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BODISEN BIOTECH, INC · 2007-12-31 BODISEN BIOTECH, INC (edgar:1178552) Free cash flow: -8027332 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7932725 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-09-016809.txt#6724 Input fundies:CapitalExpenditure: 94607 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-09-016809.txt#6764 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	−USD 6.92 million Exact value Exact value: -6919037 USD 2008-01-01 – 2008-12-31: -6919037 USD Inspect Net Income Open source Share or cite Citation for Net Income · BODISEN BIOTECH, INC · 2008-12-31 BODISEN BIOTECH, INC (edgar:1178552) Net Income: -6919037 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6919037 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6478 The citation records this snapshot. The page link may show a newer release later.	USD 6.16 million Exact value Exact value: 6161699 USD 2008-01-01 – 2008-12-31: 6161699 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BODISEN BIOTECH, INC · 2008-12-31 BODISEN BIOTECH, INC (edgar:1178552) Operating Cash Flow: 6161699 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 6161699 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6785 The citation records this snapshot. The page link may show a newer release later.	USD 64,871 Exact value Exact value: 64871 USD 2008-01-01 – 2008-12-31: 64871 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BODISEN BIOTECH, INC · 2008-12-31 BODISEN BIOTECH, INC (edgar:1178552) Capital Expenditure: 64871 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 64871 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6825 The citation records this snapshot. The page link may show a newer release later.	USD 6.1 million Calculation and evidence 6161699 − 64871 USD Exact free cash flow: 6096828 USD 2008-01-01 – 2008-12-31: 6161699 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 64871 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BODISEN BIOTECH, INC · 2008-12-31 BODISEN BIOTECH, INC (edgar:1178552) Free cash flow: 6096828 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 6161699 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6785 Input fundies:CapitalExpenditure: 64871 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6825 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	USD 510,289 Exact value Exact value: 510289 USD 2009-01-01 – 2009-12-31: 510289 USD Inspect Net Income Open source Share or cite Citation for Net Income · BODISEN BIOTECH, INC · 2009-12-31 BODISEN BIOTECH, INC (edgar:1178552) Net Income: 510289 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 510289 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6478 The citation records this snapshot. The page link may show a newer release later.	USD 79,511 Exact value Exact value: 79511 USD 2009-01-01 – 2009-12-31: 79511 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · BODISEN BIOTECH, INC · 2009-12-31 BODISEN BIOTECH, INC (edgar:1178552) Operating Cash Flow: 79511 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 79511 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6785 The citation records this snapshot. The page link may show a newer release later.	USD 0 Exact value Exact value: 0 USD 2009-01-01 – 2009-12-31: 0 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · BODISEN BIOTECH, INC · 2009-12-31 BODISEN BIOTECH, INC (edgar:1178552) Capital Expenditure: 0 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6825 The citation records this snapshot. The page link may show a newer release later.	USD 79,511 Calculation and evidence 79511 − 0 USD Exact free cash flow: 79511 USD 2009-01-01 – 2009-12-31: 79511 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 0 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · BODISEN BIOTECH, INC · 2009-12-31 BODISEN BIOTECH, INC (edgar:1178552) Free cash flow: 79511 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T18:27:07Z Snapshot: a02a52b7781aeb528634bb9815ad830503bfe61bdf1f996ab2711de56feb96c3 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1178552?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 79511 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6785 Input fundies:CapitalExpenditure: 0 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1178552/0001144204-10-016757.txt#6825 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

55 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001178552, 1178552, edgar:1178552

Also known as STRATABID COM INC

BODISEN BIOTECH, INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2009 2009-01-01 – 2009-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation